Do analysts recommend BNBX or APVO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aptevo Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer BNBX or HCWB?

HCW Biologics has a consensus price target of $30.00, indicating a potential upside of 1,664.71%. Given HCW Biologics' stronger consensus rating and higher possible upside, analysts plainly believe HCW Biologics is more favorable than Applied Dna Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 HCW Biologics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to BNBX or HCWB?

In the previous week, Applied Dna Sciences had 4 more articles in the media than HCW Biologics. MarketBeat recorded 7 mentions for Applied Dna Sciences and 3 mentions for HCW Biologics. HCW Biologics' average media sentiment score of 0.62 beat Applied Dna Sciences' score of 0.00 indicating that HCW Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Applied Dna Sciences 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HCW Biologics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BNBX or TCRT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Alaunos Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend BNBX or ONCO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Onconetix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BNBX or ONCO?

In the previous week, Applied Dna Sciences had 2 more articles in the media than Onconetix. MarketBeat recorded 7 mentions for Applied Dna Sciences and 5 mentions for Onconetix. Onconetix's average media sentiment score of 0.36 beat Applied Dna Sciences' score of 0.00 indicating that Onconetix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Applied Dna Sciences 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Onconetix 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend GNPX or BNBX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genprex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is GNPX or BNBX more profitable?

Genprex has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Genprex's return on equity of -163.12% beat Applied Dna Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Genprex N/A -163.12% -128.98% Applied Dna Sciences -1,647.25% -349.95% -283.96%

Applied Dna Sciences (BNBX) Competitors

$0.14 -0.01 (-7.93%)

As of 10:56 AM Eastern

Compare

BNBX vs. APVO, HCWB, TCRT, ONCO, and GNPX

Should you buy Applied Dna Sciences stock or one of its competitors? Applied Dna Sciences's main competitors and comparable companies include Aptevo Therapeutics (APVO), HCW Biologics (HCWB), Alaunos Therapeutics (TCRT), Onconetix (ONCO), and Genprex (GNPX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Applied Dna Sciences compare to Aptevo Therapeutics?

Applied Dna Sciences (NASDAQ:BNBX) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Aptevo Therapeutics has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Aptevo Therapeutics' return on equity of -201.49% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Aptevo Therapeutics	N/A	-201.49%	-119.21%

In the previous week, Applied Dna Sciences had 5 more articles in the media than Aptevo Therapeutics. MarketBeat recorded 7 mentions for Applied Dna Sciences and 2 mentions for Aptevo Therapeutics. Aptevo Therapeutics' average media sentiment score of 0.27 beat Applied Dna Sciences' score of 0.00 indicating that Aptevo Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Aptevo Therapeutics	Neutral

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 8.1% of Aptevo Therapeutics shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 0.4% of Aptevo Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aptevo Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Aptevo Therapeutics has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market.

Applied Dna Sciences has higher revenue and earnings than Aptevo Therapeutics. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Aptevo Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.40	-$15.16M	-$3.33	N/A
Aptevo Therapeutics	N/A	N/A	-$25.97M	-$51.83	N/A

Summary

Applied Dna Sciences and Aptevo Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.

How does Applied Dna Sciences compare to HCW Biologics?

Applied Dna Sciences (NASDAQ:BNBX) and HCW Biologics (NASDAQ:HCWB) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

HCW Biologics has a consensus price target of $30.00, indicating a potential upside of 1,664.71%. Given HCW Biologics' stronger consensus rating and higher possible upside, analysts plainly believe HCW Biologics is more favorable than Applied Dna Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
HCW Biologics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HCW Biologics has a net margin of -83.03% compared to Applied Dna Sciences' net margin of -1,647.25%. HCW Biologics' return on equity of -262.33% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
HCW Biologics	-83.03%	-262.33%	-34.90%

In the previous week, Applied Dna Sciences had 4 more articles in the media than HCW Biologics. MarketBeat recorded 7 mentions for Applied Dna Sciences and 3 mentions for HCW Biologics. HCW Biologics' average media sentiment score of 0.62 beat Applied Dna Sciences' score of 0.00 indicating that HCW Biologics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Applied Dna Sciences	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HCW Biologics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HCW Biologics has lower revenue, but higher earnings than Applied Dna Sciences. HCW Biologics is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.40	-$15.16M	-$3.33	N/A
HCW Biologics	$50K	62.56	-$7.96M	-$27.60	N/A

22.2% of Applied Dna Sciences shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by company insiders. Comparatively, 9.1% of HCW Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Applied Dna Sciences has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, HCW Biologics has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market.

Summary

HCW Biologics beats Applied Dna Sciences on 11 of the 16 factors compared between the two stocks.

How does Applied Dna Sciences compare to Alaunos Therapeutics?

Applied Dna Sciences (NASDAQ:BNBX) and Alaunos Therapeutics (NASDAQ:TCRT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

22.2% of Applied Dna Sciences shares are held by institutional investors. Comparatively, 27.7% of Alaunos Therapeutics shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by company insiders. Comparatively, 16.1% of Alaunos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Applied Dna Sciences had 6 more articles in the media than Alaunos Therapeutics. MarketBeat recorded 7 mentions for Applied Dna Sciences and 1 mentions for Alaunos Therapeutics. Alaunos Therapeutics' average media sentiment score of 1.79 beat Applied Dna Sciences' score of 0.00 indicating that Alaunos Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Alaunos Therapeutics	Very Positive

Alaunos Therapeutics has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Alaunos Therapeutics' return on equity of -232.60% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Alaunos Therapeutics	N/A	-232.60%	-158.99%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Alaunos Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Alaunos Therapeutics has a beta of -0.97, suggesting that its share price is 197% less volatile than the broader market.

Alaunos Therapeutics has lower revenue, but higher earnings than Applied Dna Sciences. Alaunos Therapeutics is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.40	-$15.16M	-$3.33	N/A
Alaunos Therapeutics	N/A	N/A	-$4.18M	-$1.91	N/A

Summary

Alaunos Therapeutics beats Applied Dna Sciences on 8 of the 12 factors compared between the two stocks.

How does Applied Dna Sciences compare to Onconetix?

Applied Dna Sciences (NASDAQ:BNBX) and Onconetix (NASDAQ:ONCO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Onconetix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Onconetix has lower revenue, but higher earnings than Applied Dna Sciences. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Onconetix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.40	-$15.16M	-$3.33	N/A
Onconetix	$810K	3.91	-$14.03M	$248.12	0.00

In the previous week, Applied Dna Sciences had 2 more articles in the media than Onconetix. MarketBeat recorded 7 mentions for Applied Dna Sciences and 5 mentions for Onconetix. Onconetix's average media sentiment score of 0.36 beat Applied Dna Sciences' score of 0.00 indicating that Onconetix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Applied Dna Sciences	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Onconetix	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 23.9% of Onconetix shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 0.3% of Onconetix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Applied Dna Sciences has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Onconetix has a beta of 2.68, meaning that its stock price is 168% more volatile than the broader market.

Onconetix has a net margin of -1,575.89% compared to Applied Dna Sciences' net margin of -1,647.25%. Onconetix's return on equity of -91.95% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Onconetix	-1,575.89%	-91.95%	-53.76%

Summary

Onconetix beats Applied Dna Sciences on 10 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to Genprex?

Genprex (NASDAQ:GNPX) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genprex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Applied Dna Sciences had 6 more articles in the media than Genprex. MarketBeat recorded 7 mentions for Applied Dna Sciences and 1 mentions for Genprex. Genprex's average media sentiment score of 1.82 beat Applied Dna Sciences' score of 0.00 indicating that Genprex is being referred to more favorably in the media.

Company	Overall Sentiment
Genprex	Very Positive
Applied Dna Sciences	Neutral

Genprex has a beta of -0.94, suggesting that its stock price is 194% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

14.1% of Genprex shares are held by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are held by institutional investors. 0.3% of Genprex shares are held by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Applied Dna Sciences has higher revenue and earnings than Genprex. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Genprex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genprex	N/A	N/A	-$16.23M	-$133.36	N/A
Applied Dna Sciences	$2.09M	0.40	-$15.16M	-$3.33	N/A

Genprex has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Genprex's return on equity of -163.12% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genprex	N/A	-163.12%	-128.98%
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%

Summary

Applied Dna Sciences beats Genprex on 7 of the 12 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNBX vs. The Competition

Export

Metric	Applied Dna Sciences	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$842K	$3.89B	$7.14B	$13.01B
Dividend Yield	N/A	3.63%	2.52%	14.40%
P/E Ratio	-0.04	13.50	273.33	25.72
Price / Sales	0.40	1,295.73	656.03	105.62
Price / Cash	N/A	120.99	79.75	52.18
Price / Book	0.09	15.63	10.50	6.25
Net Income	-$15.16M	-$22.67M	$3.49B	$360.72M
7 Day Performance	-1.24%	-2.68%	-1.96%	-1.99%
1 Month Performance	-11.01%	-8.64%	-5.12%	-3.51%
1 Year Performance	N/A	23.81%	10.37%	2.45%

Applied Dna Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNBX Applied Dna Sciences	0.043 of 5 stars	$0.14 -7.9%	N/A	N/A	$842K	$2.09M	N/A	70	News Coverage Gap Down
APVO Aptevo Therapeutics	0.4464 of 5 stars	$1.89 +2.2%	N/A	-93.0%	$3.35M	N/A	N/A	33	Short Interest Increase
HCWB HCW Biologics	3.8879 of 5 stars	$1.66 -8.3%	$30.00 +1,707.2%	-92.3%	$3.32M	$50K	N/A	35
TCRT Alaunos Therapeutics	1.0044 of 5 stars	$1.15 -9.4%	N/A	-63.2%	$3.23M	N/A	N/A	1	Gap Down
ONCO Onconetix	1.6344 of 5 stars	$0.91 +33.2%	N/A	-99.5%	$2.99M	$810K	0.00	2	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 10/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Applied Dna Sciences (BNBX) Competitors

BNBX vs. APVO, HCWB, TCRT, ONCO, and GNPX

How does Applied Dna Sciences compare to Aptevo Therapeutics?

Summary

How does Applied Dna Sciences compare to HCW Biologics?

Summary

How does Applied Dna Sciences compare to Alaunos Therapeutics?

Summary

How does Applied Dna Sciences compare to Onconetix?

Summary

How does Applied Dna Sciences compare to Genprex?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Applied Dna Sciences (BNBX) Competitors

BNBX vs. APVO, HCWB, TCRT, ONCO, and GNPX

How does Applied Dna Sciences compare to Aptevo Therapeutics?

Is BNBX or APVO more profitable?

Does the media prefer BNBX or APVO?

Do institutionals & insiders believe in BNBX or APVO?

Do analysts recommend BNBX or APVO?

Which has more risk and volatility, BNBX or APVO?

Which has higher earnings and valuation, BNBX or APVO?

Summary

How does Applied Dna Sciences compare to HCW Biologics?

Do analysts prefer BNBX or HCWB?

Is BNBX or HCWB more profitable?

Does the media refer more to BNBX or HCWB?

Which has better earnings and valuation, BNBX or HCWB?

Do insiders and institutionals believe in BNBX or HCWB?

Which has more risk & volatility, BNBX or HCWB?

Summary

How does Applied Dna Sciences compare to Alaunos Therapeutics?

Do institutionals and insiders believe in BNBX or TCRT?

Does the media refer more to BNBX or TCRT?

Is BNBX or TCRT more profitable?

Do analysts prefer BNBX or TCRT?

Which has more volatility and risk, BNBX or TCRT?

Which has preferable earnings & valuation, BNBX or TCRT?

Summary

How does Applied Dna Sciences compare to Onconetix?

Do analysts recommend BNBX or ONCO?

Which has stronger earnings and valuation, BNBX or ONCO?

Does the media favor BNBX or ONCO?

Do institutionals and insiders believe in BNBX or ONCO?

Which has more risk and volatility, BNBX or ONCO?

Is BNBX or ONCO more profitable?

Summary

How does Applied Dna Sciences compare to Genprex?

Do analysts recommend GNPX or BNBX?

Does the media prefer GNPX or BNBX?

Which has more volatility & risk, GNPX or BNBX?

Do insiders & institutionals hold more shares of GNPX or BNBX?

Which has higher earnings & valuation, GNPX or BNBX?

Is GNPX or BNBX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools